Effect of lysozyme dimer injections on results of intramammary treatment of acute mastitis in cows;Wpływ iniekcji dimeru lizozymu na wyniki dowymieniowego leczenia ostrych zapaleń gruczołu mlekowego u krów

Medycyna Weterynaryjna

Volumn 62, Issue 12, 2006, Pages 1395-1399

  Malinowski, Edward ^a,b   Niewitecki, Wiesław ^a   Nadolny, Marek ^a   Lassa, Henryka ^a   Smulski, Sebastian ^a  

^a NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

^b NONE   (Poland)

Author keywords

Cow; Intramammary treatment; Lysozyme dimer; Mastitis

Indexed keywords

ARCANOBACTERIUM PYOGENES; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33846127461     PISSN: 00258628     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Burton J. L., Erskine R. J.: Immunity and mastitis. Some new ideas for an old disease. Vet. Clin. North. Am. Food Anim. Pract. 2003, 19, 1-45.
2. Constable P. D., Morin D. E.: Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline. J. Am. Vet. Med. Assoc. 2002, 221, 103-108.
3. Donlan R. M.: Role of biofilms in antimicrobial resistance. A. S. A. I. O. J. 2000, 46, 47-52.
4. Erskine R. J., Bartlett P. C., VanLente J. L., Phipps C. R.: Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J. Dairy Sci. 2002, 85, 2571-2575.
5. Gruet P., Maincent P., Berthelot X., Kaltsatos V.: Bovine mastitis and intramammary drug delivery: review and perspectives. Adv. Drug Deliv. Rev. 2001, 50, 245-259.
6. Hillerton J. E., Kliem K. E.: Effective treatment of Streptococcus uberis clinical mastitis to minimize the use of antibiotics. J. Dairy Sci. 2002, 85, 1009-1014.
7. Hoe F. S., Ruegg P. L.: Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J. Am. Vet. Med. Assoc. 2005, 227, 1461-1468.
8. Kiczka W.: Od monomeru do dimeru lizozymu. Życie Wet. 1994, 69, 131-136.
9. Malinowski E., Kłossowska A., Szalbierz M., Markiewicz H.: Skuteczność leczenia klinicznych postaci mastitis przy zastosowaniu niektórych preparatów i połaczeń antybiotyków z kwasem acetylosalicylowym i chlormetyna̧. Medycyna Wet. 1993, 49, 354-356.
10. Malinowski E., Dudko P., Kłossowska A., Markiewicz H., Szalbierz M., Branicki T., Kuźma R., Janicki Cz.: Efektywność Lydium-KLP w leczeniu mastitis subclinica. Medycyna Wet. 1995, 51, 156-159.
11. Malinowski E., Kłossowska A., Niewitecki W., Kaczmarowski M.: Combined method of acute and chronic mastitis treatment with the use of lysozyme dimer and antibiotics. Proc. IDF Inter. Symp. Immunol. Ruminant Mammary Gland. Stresa, Italy 2000, s. 376-378.
12. Malinowski E., Kłossowska A.: Diagnostyka zakażeń i zapaleń wymienia. Wyd. PIWet. Puławy 2002, s. 5-96.
13. Malinowski E.: Trials for an improvement of the efficacy of cows clinical mastitis treatment a review. Achievements and Prospects of Ruminant Medicine. Puławy 2005, 477-489.
14. McDougal S.: Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin. N. Z. Vet. J. 2003, 51, 11-116.
15. Mehrzad J., Duchateau L., Burvenich C.: Influence of resident milk neutrophils chemiluminescence and viability and severity of bovine coliform mastitis. Mastitis in dairy production. Wageningen Academic Publishers. 2005, 178-184.
16. Melchior M. B., Fink-Gremmels J., Gaastra W.: In vitro susceptibility of biofilm growing Staphylococcus aureus isolated for 10 antibiotics. Mastitis in dairy production. Wageningen Academic Publishers 2005, 302-306.
17. Milne M. H., Biggs A. M., Barrett D. C., Young F.J., Doherty S., Innocent S. T., Fitzpatrick J. L.: Treatment of persistent intramammary infections with Streptococcus uberis in dairy cows. Vet. Rec. 2005, 157, 245-250.
18. Obmińska-Mrukowicz B., Szczypka M., Gaweda B.: Modulation of murine macrophages and T lymphocytes by lysozyme dimer. Pol. J. Vet. Sci. 2002, 5, 237-241.
19. Oliver S. P., Almeida R. A., Gillespie B. E., Headrick S. J., Dowlen H. H., Johnson D. L., Lamar K. C., Chester S. T., Moseley W. M.: Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle. J. Dairy Sci. 2004, 87, 3322-3329.
20. Owens W. E., Ray C. H., Watt J. L., Yancey R. J.: Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis. J. Dairy Sci. 1997, 80, 313-317.
21. Owens W. E., Nickerson S. C., Ray C. H.: Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation. J. Dairy Sci. 1999, 82, 645-647.
22. Paape M. J., Bannerman D. D., Zhao X., Lee J. W.: The bovine neutrophil: Structure and function in blood and milk. Vet. Res. 2003, 34, 597-627.
23. Philpot W.: Strategies for handling mastitis problem herds. Achievements and prospects of ruminant medicine. Pulawy 2005, 22-30.
24. Prees du J. H.: Bovine mastitis therapy and why it fails. J. S. Afr. Vet. Assoc. 2000, 71, 201-208(3).
25. Pyörälä S.: New strategies to prevent mastitis. Reprod. Dom. Anim. 2002, 37, 211-216.
26. Riollet C., Reinard P., Poutrel B.: Cells and cytokines in inflammatory secretions of bovine mammary gland. Adv. Axp. Med. Biol. 2000, 480, 247-258.
27. Roberson J. R., Warnick L. D., Moore G.: Mild to moderate clinical mastitis: efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. J. Dairy Sci. 2004, 87, 583-592.
28. Rymuszka A., Studnicka M., Siwicki., Sierosławska A., Bownik A.: The immunomodulatory effects of the dimer of lysozyme (KLP-602) in carp (Ciprinus carpio L.) - in vivo study. Ecotoxicol. Environ. Saf. 2005, 61, 121-127.
29. Sandholm M., Kaartinen L., Pyörälä S.: Bovine mastitis - why does antibiotic therapy not always work? An overview. J. Vet. Pharmacol. Ther. 1990, 13, 248-260.
30. Saran A., Leitner G.: Interactions between bacteria, immunity and therapy in the mammary gland. Proc. IDF Inter. Symp. Immunol. Ruminant Mammary Gland. Stresa, Italy 2000, s. 290-297.
31. Schmedt G. H., Tenhagen B. A., Kutzer P., Forderung D., Heuwieser W.: Do lactoferrin lysozyme and the lactoperoxidase-thiocyanate-hydrogen peroxide system cause negative microbiological results in mastitis secretion. Dt. Tierärztl. Wsehr. 2002, 109, 300-305.
32. nd Inter. Symp. Mastitis Milk Quality. Vancouver, BC, Canada 2001, s. 44-47.
33. Serieys F., Raguet Y., Goby L., Schmidt H., Friton G.: Comparative efficacy of local and systemic antibiotic treatment in lactating cows with clinical mastitis. J. Dairy Sci. 2005, 88, 93-99.
34. Sol J., Sampimon O. C., Barkema H. W., Schukken Y. H.: Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. J. Dairy Sci. 2000, 83, 278-284.
35. Taponen S., Dredge K., Henriksson B., Pyyhtiä A. M., Suojala L., Junni R., Heinonen K., Pyörälä S.: Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin G plus neomycin in bovine clinical mastitis caused by penicillin-susceptible, gram-positive bacteria - a double blind field study. J. Vet. Pharmacol. Ther. 2003, 26, 193-198.
36. nd Inter. Symp. Mastitis Milk Quality. Vancouver, BC, Canada 2001, s. 538-539.
37. Vaz A., Paterno M., Marca A.: Vaccination of lactating cows improves the efficacy of anti-Staphylococcus intramammary therapy. Med. Vet. Quebec 2004, 34, 169.
38. Wenz J. R., Barrington G. M., Garry F. B., McSweeney K. D., Dinsmore R. P., Goodell G., Callan R. J.: Bacteriemia associated with naturally occurring acute coliform mastitis in dairy cows. J. Am. Vet. Med. Assoc. 2001, 219, 976-981.
39. Wilson D. J., Sears F. M., Gonzalez R. N., Smith B. S., Schulte H. K. Bennett G. J., Das H. H., Johnson C. K.: Efficacy of florfenicol for treatment of clinical and subclinical bovine mastitis. Am. J. Vet. Res. 1966, 57, 526-528.